Does Rallies show Form 4 insider transactions for CCRN?

Yes. Rallies tracks CCRN insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is CCRN research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CCRN. It does not provide personalized investment advice.

CCRN (Cross Country Healthcare Inc) Stock Analysis - Insider Trades

Cross Country Healthcare Inc (CCRN) is a publicly traded Healthcare sector company. As of May 21, 2026, CCRN trades at $13.11 with a market cap of $406.21M and a P/E ratio of -4.30. CCRN moved +0.08% today. Year to date, CCRN is +54.05%; over the trailing twelve months it is -4.93%. Its 52-week range spans $7.43 to $18.33. Analyst consensus is neutral with an average price target of $12.38. Rallies surfaces CCRN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading CCRN stock inside the company?

Recent CCRN insider activity includes McDonald Colin Patrick sold 6.20K, CASH W LARRY bought 200, CASH W LARRY bought 4.80K, Grieco Cynthia Ann sold 1.95K, and Mote Karen sold 13.83K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

CCRN Key Metrics

Key financial metrics for CCRN
Metric	Value
Price	$13.11
Market Cap	$406.21M
P/E Ratio	-4.30
EPS	$-3.05
Dividend Yield	0.00%
52-Week High	$18.33
52-Week Low	$7.43
Volume	25
Avg Volume	0
Revenue (TTM)	$1.00B
Net Income	$-98.63M
Gross Margin	20.21%

Recent CCRN Insider Trades

McDonald Colin Patrick sold 6.20K (~$60.15K) on Mar 11, 2026.
CASH W LARRY bought 200 (~$1.62K) on Dec 9, 2025.
CASH W LARRY bought 4.80K (~$39.21K) on Dec 9, 2025.
Grieco Cynthia Ann sold 1.95K (~$33.47K) on Aug 2, 2024.
Mote Karen sold 13.83K (~$236.20K) on Aug 2, 2024.

Latest CCRN News

Knox Lane to Buy Cross Country Healthcare for $437 Million at 31% Premium — May 6, 2026
Cross Country Healthcare Eyes Over $1B Revenue, 4%–5% EBITDA by 2026 with $400M Pipeline — Mar 5, 2026
Cross Country Healthcare Q4 Revenue Down 23.6%, EPS -$0.06; Guides $235M-$240M Q1 Revenue — Mar 5, 2026

CCRN Analyst Consensus

7 analysts cover CCRN: 0 strong buy, 0 buy, 7 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $12.38.

Common questions about CCRN

Who is trading CCRN stock inside the company?: Recent CCRN insider activity includes McDonald Colin Patrick sold 6.20K, CASH W LARRY bought 200, CASH W LARRY bought 4.80K, Grieco Cynthia Ann sold 1.95K, and Mote Karen sold 13.83K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for CCRN?: Yes. Rallies tracks CCRN insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is CCRN research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CCRN. It does not provide personalized investment advice.